---
figid: PMC3930845__11899_2013_196_Fig1_HTML
figlink: /pmc/articles/PMC3930845/figure/Fig1/
number: F1
caption: BCR-ABL levels govern engagement and evasion of tumor suppression in hematopoietic
  precursors, thereby controlling CML transformation. In normal hematopoietic stem
  cells, p53 negatively regulates self-renewal and p53 pathway activation is suppressed
  (left). During CML evolution, increasing BCR-ABL expression level must be tolerated
  (middle) by adjustment of pathways that suppress Arf-p53 activation (arm A), or
  by alternatively mutating the Arf-p53 checkpoint to resolve a pressure on this pathway
  (arm B). The consequence of both scenarios (arm A or B) would be tolerance of high-level
  BCR-ABL, which results in BCR-ABL overexpression induced transformation and CML
  progression
pmcid: PMC3930845
papertitle: Maintaining Low BCR-ABL Signaling Output to Restrict CML Progression and
  Enable Persistence.
reftext: Andreas Burchert. Curr Hematol Malig Rep. 2014;9(1):9-16.
pmc_ranked_result_index: '126383'
pathway_score: 0.8292603
filename: 11899_2013_196_Fig1_HTML.jpg
figtitle: BCR-ABL levels govern engagement and evasion of tumor suppression in hematopoietic
  precursors, thereby controlling CML transformation
year: '2014'
organisms: Homo sapiens
ndex: 384b54dd-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3930845__11899_2013_196_Fig1_HTML.html
  '@type': Dataset
  description: BCR-ABL levels govern engagement and evasion of tumor suppression in
    hematopoietic precursors, thereby controlling CML transformation. In normal hematopoietic
    stem cells, p53 negatively regulates self-renewal and p53 pathway activation is
    suppressed (left). During CML evolution, increasing BCR-ABL expression level must
    be tolerated (middle) by adjustment of pathways that suppress Arf-p53 activation
    (arm A), or by alternatively mutating the Arf-p53 checkpoint to resolve a pressure
    on this pathway (arm B). The consequence of both scenarios (arm A or B) would
    be tolerance of high-level BCR-ABL, which results in BCR-ABL overexpression induced
    transformation and CML progression
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXO6
  - TP53
  - FOXO3
  - FOXO1
  - BCR
  - CDKN2A
  - PTEN
  - BCL6
  - TGFB3
  - FOXO4
  - TGFB1
  - TGFB2
  - Cancer
genes:
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: CML
  symbol: CML
  source: hgnc_alias_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: Arf
  symbol: ARF
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Bcl-6
  symbol: BCL6
  source: hgnc_symbol
  hgnc_symbol: BCL6
  entrez: '604'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3930845__F1
redirect_from: /figures/PMC3930845__F1
figtype: Figure
---
